Cargando…

How Do We “Validate” a QSP Model?

Detalles Bibliográficos
Autor principal:	Kirouac, Daniel C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157666/ https://www.ncbi.nlm.nih.gov/pubmed/29761661 http://dx.doi.org/10.1002/psp4.12310

Ejemplares similares

Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and Estimation
por: Ribba, B, et al.
Publicado: (2017)

QSP Versus the Rest: Let the Competition Commence!
por: Mistry, Hitesh B.
Publicado: (2018)

Benchmarking QSP Models Against Simple Models: A Path to Improved Comprehension and Predictive Performance
por: Stein, Andrew M., et al.
Publicado: (2018)

FDA Advisory Meeting Clinical Pharmacology Review Utilizes a Quantitative Systems Pharmacology (QSP) Model: A Watershed Moment?
por: Peterson, MC, et al.
Publicado: (2015)

Malaria: How Are We Doing and How Can We Do Better?
por: Rosenthal, Philip J., et al.
Publicado: (2019)

Management of Cryptococcosis: How Are We Doing?
por: Perfect, John R
Publicado: (2007)

GPS for QSP: A Summary of the ACoP6 Symposium on Quantitative Systems Pharmacology and a Stage for Near‐Term Efforts in the Field
por: Musante, CJ, et al.
Publicado: (2016)

In medicine, how do we machine learn anything real?
por: Ghassemi, Marzyeh, et al.
Publicado: (2022)

How Do We Explore Heterogeneity in Turnover of Musculoskeletal Proteins?
por: Agergaard, Jakob, et al.
Publicado: (2021)

Modern Compact Cities: How Much Greenery Do We Need?
por: Russo, Alessio, et al.
Publicado: (2018)

Public Data Archiving in Ecology and Evolution: How Well Are We Doing?
por: Roche, Dominique G., et al.
Publicado: (2015)

How do we teach surgical residents in the COVID-19 era?
por: Okland, Tyler S., et al.
Publicado: (2020)

Tackling Loneliness and Isolation in Older Adults With Virtual Reality: How do We Move Forward?
por: Finnegan, Daniel J., et al.
Publicado: (2023)

Moving toward multimedia electronic health records: how do we get there?
por: Seto, Belinda, et al.
Publicado: (2012)

Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem?
por: Dowdy, Steven F.
Publicado: (2023)

Insect Cultural Services: How Insects Have Changed Our Lives and How Can We Do Better for Them
por: Duffus, Natalie E., et al.
Publicado: (2021)

Current practices for QSP model assessment: an IQ consortium survey
por: Chan, Jason R., et al.
Publicado: (2022)

Visitation restrictions: is it right and how do we support families in the NICU during COVID-19?
por: Murray, Peter D., et al.
Publicado: (2020)

Do we face a third revolution in human history? If so, how will public health respond?
por: Hanlon, Phil, et al.
Publicado: (2008)

A quantitative systems pharmacology (QSP) model for Pneumocystis treatment in mice
por: Liu, Guan-Sheng, et al.
Publicado: (2018)

How do we forecast tomorrow’s transfusion? Prehospital transfusion
por: Yazer, Mark H., et al.
Publicado: (2023)

Evaluating how we evaluate
por: Vale, Ronald D.
Publicado: (2012)

Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?
por: Ashburner, Jeffrey M., et al.
Publicado: (2021)

Do we need a new levodopa?
por: Müller, Thomas
Publicado: (2016)

How do we prepare ourselves for a new paradigm of medicine to advance the treatment of pediatric acute lymphoblastic leukemia?
por: Park, Kyung Duk
Publicado: (2014)

Using machine learning surrogate modeling for faster QSP VP cohort generation
por: Myers, Renée C., et al.
Publicado: (2023)

How Do We Combat Bogus Medicines in the Age of the COVID-19 Pandemic?
por: Tesfaye, Wubshet, et al.
Publicado: (2020)

Integrating blue: How do we make nationally determined contributions work for both blue carbon and local coastal communities?
por: Dencer-Brown, Amrit Melissa, et al.
Publicado: (2022)

Correction to: A quantitative systems pharmacology (QSP) model for Pneumocystis treatment in mice
por: Liu, Guan-Sheng, et al.
Publicado: (2019)

A QSP model of prostate cancer immunotherapy to identify effective combination therapies
por: Coletti, Roberta, et al.
Publicado: (2020)

Do We Need Biomarkers for Disc Degeneration?
por: Gruber, Helen E., et al.
Publicado: (2007)

Do We Need to Use Bats as Bioindicators?
por: Russo, Danilo, et al.
Publicado: (2021)

Quantitative systems pharmacology of the eye: Tools and data for ocular QSP
por: Kuepfer, Lars, et al.
Publicado: (2023)

How do I/we forecast tomorrows’ transfusion: Blood components
por: Pereyra, Nicolas, et al.
Publicado: (2023)

Health Literacy and People with Intellectual Disabilities: What We Know, What We Do Not Know, and What We Need: A Theoretical Discourse
por: Geukes, Cornelia, et al.
Publicado: (2019)

COVID toes: where do we stand with the current evidence?
por: Baeck, Marie, et al.
Publicado: (2021)

What Do We Know About Remdesivir Drug Interactions?
por: Yang, Katherine
Publicado: (2020)

Why are people antiscience, and what can we do about it?
por: Philipp-Muller, Aviva, et al.
Publicado: (2022)

Preclinical QSP Modeling in the Pharmaceutical Industry: An IQ Consortium Survey Examining the Current Landscape
por: Nijsen, Marjoleen J.M.A., et al.
Publicado: (2018)

A model qualification method for mechanistic physiological QSP models to support model‐informed drug development
por: Friedrich, CM
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q3o9h7erdbias1j83jput3khk1